OR WAIT null SECS
April 09, 2009
Also, Genzyme and Bayer HealthCare form agreement; FDA releases draft guidances; TransMolecular appointed Robert Radie president and CEO
April 02, 2009
Editors' Picks of Pharmaceutical Science & Technology Innovations
Also, SOCMA changes name; two FDA approvals; Biogen Idec names chief operating officer; more...
Obama's cost-containment and science-innovation initiatives need to overlap.
The financial and economic downturn is likey to have long-term implications for outsourcing.
The role of automation suppliers is transforming to meet the pharma industry's demand for change.
March 26, 2009
Also, Hospira to reduce workforce; WuXi AppTech makes senior appointments; more...
March 19, 2009
Also, Genzyme receives warning letter; Mesa Laboratories appoints John J. Sullivan CEO and a member of the board of directors; more...
March 12, 2009
Also, Penn Pharma to expand; stem cell research funding ban lifted; Bristol-Myers Squibb made senior appointments; more...
March 05, 2009
Also, Schering-Plough's vaccine unit, Nobilon, formed an agreement with the World Health Organization; Ore Pharmaceuticals named president and CEO; more...